Skip to main content
SpringerLink
Log in

One-time universal HBsAg screening for hepatitis B cost saving in the USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Toy M, et al. Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. Clinical Infectious Diseases : 6 May 2021

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

One-time universal HBsAg screening for hepatitis B cost saving in the USA. PharmacoEcon Outcomes News 879, 21 (2021). https://doi.org/10.1007/s40274-021-7744-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7744-6

Search

Navigation